Ardent Health (ARDT) Cash & Equivalents (2023 - 2026)

Ardent Health has reported Cash & Equivalents for 4 years, with the latest figure at $609.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 23.16% year-over-year to $609.7 million; the trailing twelve-month figure through Mar 2026 stood at $609.7 million (up 23.16% YoY), and the FY2025 full-year result was $709.6 million, up 27.45% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $609.7 million, down from $709.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $709.6 million in Q4 2025, with the low at $334.5 million in Q2 2024.
• Average Cash & Equivalents over 4 years is $539.6 million, with a median of $556.8 million recorded in 2024.
• Peak annual rise in Cash & Equivalents reached 61.6% in 2025, while the deepest fall reached 8.22% in 2025.
• Tracing ARDT's Cash & Equivalents over 4 years: stood at $437.6 million in 2023, then advanced by 27.24% to $556.8 million in 2024, then increased by 27.45% to $709.6 million in 2025, then decreased by 14.08% to $609.7 million in 2026.
• The last three Cash & Equivalents figures came in at $609.7 million (Q1 2026), $709.6 million (Q4 2025), and $609.4 million (Q3 2025), per Business Quant data.

Peer Comparison